Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04951102 · ClinicalTrials.gov registry record · NA
An Electronic Shared Decision-Making Application to Improve Asthma Outcomes
A NA study of Asthma, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT04951102: Completed NA study of Asthma, sponsored by University of Michigan.
NCT04951102 is a NA study of Asthma that has completed, run by University of Michigan. The registered enrollment target is 81 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04951102, a NA study of Asthma, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will increase knowledge about the feasibility and effect on patient satisfaction and clinical outcomes of using an electronic Shared Decision Making (SDM) application (app) for patients with asthma in the allergy/immunology clinic visit setting. SDM is defined as an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients are supported to consider options and make informed choices.
Primary Outcome
Patient satisfaction as determined by Patient Satisfaction Questionnaire responses. Questions will consist of the SDM-Q-9 (psychometrically validated measures for shared decision-making from the perspectives of patients), questions regarding satisfaction with content covered during the visit, and questions regarding satisfaction with the overall communication between the patient and physician.
Conditions Studied
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Electronic Asthma Shared Decision-Making App
- BEHAVIORAL Shared Decision Making Physician Training Video
- BEHAVIORAL Electronic Asthma Shared Decision-Making App- Patient Data
Study Locations (1)
Michigan
- Michigan Medicine, University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2022-09-14 |
| Phase | NA |
What the finished NCT04951102 record still lists
NCT04951102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 4 interventions - of which Standard Care is the first listed.
NCT04951102 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04951102 about?
NCT04951102 is a clinical study titled "An Electronic Shared Decision-Making Application to Improve Asthma Outcomes". This study will increase knowledge about the feasibility and effect on patient satisfaction and clinical outcomes of using an electronic Shared Decision Making (SDM) application (app) for patients with asthma in the allergy/immunology clinic visit setting. SDM is defined as an approach where clinici...
What is the current status of trial NCT04951102?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2021-03-03. Estimated completion is 2022-09-14.
What conditions does trial NCT04951102 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT04951102?
The interventions under investigation include: Standard Care (BEHAVIORAL), Electronic Asthma Shared Decision-Making App (BEHAVIORAL), Shared Decision Making Physician Training Video (BEHAVIORAL), Electronic Asthma Shared Decision-Making App- Patient Data (BEHAVIORAL).
Who is sponsoring clinical trial NCT04951102?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04951102 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04951102's enrollment target sits among peer trials
81 224th of 374 higher than 150 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI